Vitamin Shoppe, Inc (NYSE:VSI) will post its quarterly earnings results before the market opens on Tuesday, October 31st. Analysts expect Vitamin Shoppe to post earnings of $0.18 per share for the quarter.

Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.39 by ($0.16). The business had revenue of $304.84 million for the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a negative net margin of 11.98% and a positive return on equity of 8.33%. The business’s revenue was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.55 EPS. On average, analysts expect Vitamin Shoppe to post $0.72 EPS for the current fiscal year and $0.69 EPS for the next fiscal year.

Vitamin Shoppe, Inc (VSI) traded down 0.485% during trading on Tuesday, hitting $5.125. 38,376 shares of the company traded hands. The firm has a 50 day moving average of $5.36 and a 200 day moving average of $10.31. The firm’s market cap is $119.02 million. Vitamin Shoppe, Inc has a one year low of $4.95 and a one year high of $28.00.

In other news, Director John D. Bowlin acquired 40,000 shares of the firm’s stock in a transaction that occurred on Friday, August 25th. The stock was acquired at an average cost of $5.50 per share, with a total value of $220,000.00. Following the acquisition, the director now owns 56,028 shares in the company, valued at $308,154. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.07% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: “Vitamin Shoppe, Inc (VSI) to Release Earnings on Tuesday” was first posted by American Banking News and is owned by of American Banking News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at

Several research analysts have recently commented on the stock. Morgan Stanley set a $8.00 price target on shares of Vitamin Shoppe and gave the stock a “hold” rating in a research note on Thursday, August 10th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and set a $6.00 price target (down previously from $13.00) on shares of Vitamin Shoppe in a research note on Thursday, August 10th. BidaskClub lowered shares of Vitamin Shoppe from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. TheStreet lowered shares of Vitamin Shoppe from a “c-” rating to a “d” rating in a research note on Wednesday, August 9th. Finally, Barclays PLC dropped their price target on shares of Vitamin Shoppe from $13.00 to $6.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 10th. Four analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $9.92.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Earnings History for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with's FREE daily email newsletter.